Nuvalent
-
USA
GSK to acquire U.S. drugmaker Nuvalent for $10.6 billion
GlaxoSmithKline headquarters in London on January 17, 2022. Hannah Mckay | Reuters UK pharmaceutical group GSK Signed an agreement to…
Read More » -
UK
GSK to buy US cancer treatment firm Nuvalent for $10.6bn | GSK
GSK’s new boss Luke Miels has signed one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) purchase of…
Read More »